MedTrace Logo

The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women

NCT07284082 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-04-22

No results posted yet for this study

Summary

Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of menopause on cardiovascular disease risk factors such as insulin resistance, hypertension, hyperlipidemia, and carotid atherosclerosis using previously collected data. The investigators will look at underlying causes for cardiovascular diseases worsening in menopausal women with HIV by looking at the role of increased inflammation in the body and whether this is altered by weight. The investigators achieve this by enrolling participants who are willing to undergo a whole body MRI.

Conditions

  • HIV
  • Menopause
  • Cardiovascular (CV) Risk
  • Carotid Arteriosclerosis
  • Body Composition

Interventions

DIAGNOSTIC_TEST

Whole body MRI

Whole body MRI will be performed as part of a study protocol

Sponsors & Collaborators

Principal Investigators

  • Rebecca Abelman, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-17
Primary Completion
2030-03-01
Completion
2030-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07284082 on ClinicalTrials.gov